Differential restenosis rate of individual coronary artery sites after multivessel angioplasty: Implications for revascularization strategy - 09/09/11
Abstract |
Background: Restenosis is a major limitation of angioplasty. In this analysis we assessed the effects of lesion site and quality of dilatation on restenosis rate in the Coronary Angioplasty versus Bypass Revascularization Investigation population who underwent angioplasty. Methods: The angiographic quality of the successful angioplasty revascularization at each site was assessed, and the subsequent restenosis rate was determined. Restenosis was defined by the need for a second angioplasty at the initial site or by surgical coronary bypass grafting at or distal to the initial site. Results: The restenosis rate was unaffected by quality of dilatation but was significantly more common in the proximal left anterior descending artery compared with other sites, whether or not optimal dilatation had been achieved (relative risk 2.0 and 1.9, respectively). Conclusion: Revascularization strategies in multivessel disease should consider the presence or absence of a proximal left anterior descending artery target. Furthermore in studies in which restenosis is an outcome of interest, an allowance should be made for the distribution of target disease. (Am Heart J 1998;135:703-8.)
Le texte complet de cet article est disponible en PDF.Plan
![]() | From the aDepartment of Cardiology, Royal Brompton Hospital/National Heart & Lung Institute, and the bDepartment of Cardiology, St Mary's Hospital/Imperial College. |
![]() ![]() | The CABRI Trial was sponsored by educational and research grants from CR Bard (USCI) Inc., The World Health Organization, and The European Society of Cardiology. |
![]() | Reprint requests: A.S. Kurbaan, MB, MRCP, Department of Cardiology, Royal Brompton Hospital, Imperial College of Science, Technology & Medicine, Sydney St., London SW3 6NP, United Kingdom |
![]() ![]() | 4/1/88149 |
Vol 135 - N° 4
P. 703-708 - avril 1998 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?